2015 annual financial data
ImmuCell 2015 Operating margin
Direct answer
Operating margin was 20.75%.
Operating income was 2,122,322 USD and net income was 1,213,239 USD.
Operating cash flow was 2,900,236 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,228,689 USD
- Operating income
- 2,122,322 USD
- Net income
- 1,213,239 USD
- Operating cash flow
- 2,900,236 USD